The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our consolidated financial
statements and the related notes and other financial information included
elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form
10-K for the year ended December 31, 2021 filed with the SEC on March 1, 2022.
In addition to historical consolidated financial information, the following
discussion contains forward-looking statements that reflect our plans,
estimates, and beliefs. Our actual results may differ materially from those
discussed in the forward-looking statements as a result of various factors,
including those set forth in Part II, Item 1A. Risk Factors and Note Regarding
Forward-Looking Statements included elsewhere in this Quarterly Report on Form
10-Q and under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K
filed with the SEC on March 1, 2022.

THE COMPANY

BRP Group, Inc. ("BRP Group," the "Company," "we," "us" or "our") is an
independent insurance distribution firm delivering tailored insurance and risk
management insights and solutions that give our Clients the peace of mind to
pursue their purpose, passion and dreams. We support our Clients, Colleagues,
Insurance Company Partners and communities through the deployment of vanguard
resources, technology and capital to drive organic and inorganic growth. When we
consistently execute for these key stakeholders, we believe that the outcome is
an increase in value for our fifth stakeholder, our shareholders. We are
innovating the industry by taking a holistic and tailored approach to risk
management, insurance and employee benefits. Our growth plan includes continuing
to recruit, train and develop industry leading talent, continuing to add
geographic representation, insurance product expertise and end-client industry
expertise via our Partnership strategy, and the continued buildout of our MGA of
the Future platform, which delivers proprietary, technology-enabled insurance
solutions to our internal Risk Advisors as well as to a growing channel of
external distribution partners. We are a destination employer supported by an
award-winning culture, powered by exceptional people and fueled by
industry-leading growth and innovation.

We represent over 1,200,000 Clients across the United States and
internationally. Our more than 3,300 Colleagues include over 520 Risk Advisors,
who are fiercely independent, relentlessly competitive and "insurance geeks." We
have approximately 125 offices in 21 states, all of which are equipped to
provide diversified products and services to empower our Clients at every stage
through our four Operating Groups.

•Middle Market provides expertly-designed commercial risk management, employee
benefits solutions and private risk management for mid-to-large-size businesses
and high net worth individuals, as well as their families.

•MainStreet offers personal insurance, commercial insurance and life and health solutions to individuals and businesses in their communities.



•Medicare offers consultation for government assistance programs and solutions,
including traditional Medicare and Medicare Advantage, to seniors and
Medicare-eligible individuals through a network of primarily independent
contractor agents. In the Medicare Operating Group, we generate commissions and
fees in the form of direct bill insurance placement and marketing income.
Marketing income is earned through co-branded marketing campaigns with our
Insurance Company Partners.

•Specialty consists of two distinct businesses. Our specialty wholesale broker
businesses deliver specialty insurers, professionals, individuals and niche
industry businesses expanded access to exclusive specialty markets, capabilities
and programs requiring complex underwriting and placement. Specialty also houses
our MGA of the Future platform, in which we deliver proprietary, technology
enabled insurance products that are then distributed (in many instances via
technology and/or API integrations) internally via our Risk Advisors in Middle
Market and MainStreet and externally via select distribution partners, with a
focus on sheltered channels where our products deliver speed, ease of use and
certainty of execution, and example of which is our national embedded renter's
insurance product sold at point of lease via integrations with property
management software providers.

In 2011, we adopted the "Azimuth" as our corporate constitution. Named after a
historical navigation tool used to find "true north," the Azimuth asserts our
core values, business basics and stakeholder promises. The ideals encompassed by
the Azimuth support our mission to deliver indispensable, tailored insurance and
risk management insights and solutions to our Clients. We strive to be regarded
as the preeminent insurance advisory firm fueled by relationships, powered by
people and exemplified by Client adoption and loyalty. This type of environment
is upheld by the distinct vernacular we use to describe our services and
culture. We are a firm, instead of an agency; we have Colleagues, instead of
employees; we have Risk Advisors, instead of producers/agents. We serve Clients
instead of customers and we refer to our acquisitions as Partnerships. We refer
to insurance brokerages that we have acquired, or in the case of asset
acquisitions, the producers, as Partners.

                                                                            

22

--------------------------------------------------------------------------------

Seasonality



The insurance brokerage market is seasonal and our results of operations are
somewhat affected by seasonal trends. Our Adjusted EBITDA and Adjusted EBITDA
Margins are typically highest in the first quarter and lowest in the fourth
quarter. This variation is primarily due to fluctuations in our revenues, while
overhead remains consistent throughout the year. Our revenues are generally
highest in the first quarter due to the impact of contingent payments received
in the first quarter from Insurance Company Partners that we cannot readily
estimate before receipt without the risk of significant reversal and a higher
degree of first quarter policy commencements and renewals in Medicare and
certain Middle Market lines of business such as employee benefits and
commercial. In addition, a higher proportion of our first quarter revenue is
derived from our highest margin businesses. As discussed further below, the
ongoing COVID-19 pandemic may continue to skew these general trends due to
reduced amounts of new business and reductions in business from existing Clients
related to the pandemic.

Partnerships can significantly impact Adjusted EBITDA and Adjusted EBITDA
Margins in a given year and may increase the amount of seasonality within the
business, especially results attributable to Partnerships that have not been
fully integrated into our business or owned by us for a full year.

PARTNERSHIPS



We utilize strategic acquisitions, which we refer to as Partnerships, to
complement and expand our business. We source Partnerships through proprietary
deal flow, competitive auctions and cultivated industry relationships. We are
currently considering Partnership opportunities in all of our Operating Groups,
including businesses to complement or expand our MGA of the Future that are
valued at higher purchase price multiples than businesses in our other Operating
Groups.

The financial impact of Partnerships may affect the comparability of our results
from period to period. Our acquisition strategy also entails certain risks,
including the risks that we may not be able to successfully source, value,
close, integrate and effectively manage businesses that we acquire. To mitigate
that risk, we have a professional team focused on finding new Partners and
integrating new Partnerships. We plan to execute on numerous Partnerships
annually as it is a key pillar in our long-term growth strategy over the next
seven years.

We completed two Partnerships for an aggregate purchase price of $26.7 million during the three months ended March 31, 2021. We did not complete any Partnerships during the three months ended March 31, 2022.



We entered into Amendment No. 5 to the JPM Credit Agreement in March 2022 for an
upsize of the aggregate principal amount of the revolving credit facility
thereunder from $475.0 million to $600.0 million. This transaction provided us
incremental capacity to assist in funding our Partnership pipeline with a
reduction in our cost of capital.

NOVEL CORONAVIRUS (COVID-19)



The impact of the COVID-19 pandemic, including changes in consumer behavior,
pandemic fears, and market downturns, as well as restrictions on business and
individual activities, has created significant volatility in the global economy
and led to severe restrictions on the level of economic activity around the
world.

Although COVID-19 vaccines are now broadly distributed and administered, there
remains significant uncertainty concerning the magnitude of the impact and the
duration of the COVID-19 pandemic. As new strains of COVID-19 develop, we may
continue to experience disruptions to our business, including due to a reduction
in our Clients` insurable exposure units and a delay in cash payments to us from
our Clients or Insurance Company Partners. Further, the impacts of inflation on
our and our Clients` businesses and the broader economy, which may be
exacerbated by the economic recovery from the COVID-19 pandemic, may also impact
our financial condition and results of operations.

In addition, the uncertainties associated with the protective and preventive
measures being put in place or recommended by both governmental entities and
other businesses, among other uncertainties, may result in delays or
modifications to our plans and initiatives.

Our Clients and Colleagues are our first priority and we have taken steps to
ensure their safety by implementing alternative working arrangement, with a
significant part of our Colleagues working in remote or hybrid environments. As
we began a phased reopening of our U.S. offices in 2021, we provided guidelines
on return to the office depending on the level of virus containment and local
health and safety regulations in each geography. This has created and may
continue to create additional risks and operational challenges and may require
us to make additional investments of time and resources across our business,
including to design, implement and enforce new workplace health and safety
protocols, as well as investments in our IT systems to support a working
environment that encompasses a mix of remote and in-person arrangements.

                                                                            

23

--------------------------------------------------------------------------------

During the pandemic, we have also funded the BRP True North Colleague Fund to assist with relief for COVID-19 and other qualifying disasters for our Colleagues experiencing extraordinary hardship and are currently matching Colleague donations dollar-for dollar.



We intend to continue to execute on our strategic plans and operational
initiatives during the pandemic. However, given the uncertainty regarding the
spread and severity of COVID-19 and its variant strains, the duration and scope
of government measures, the nature of societal responses and the adverse effects
on the national and global economy, the related financial impact on our business
cannot be accurately predicted at this time. See Part I, Item 1A. "Risk
Factors-The continued adverse effects of the COVID-19 pandemic and an
indeterminate recovery period could result in declines in business and increases
in claims that could adversely affect our business, financial condition and
results of operations" in our Annual Report on Form 10-K filed with the SEC on
March 1, 2022.

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021



The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our condensed consolidated
financial statements for the three months ended March 31, 2022 and the related
notes and other financial information included elsewhere in this report. In
addition to historical financial information, the following discussion and
analysis contains forward-looking statements that involve risks, uncertainties
and assumptions. Our actual results and timing of selected events may differ
materially from those anticipated in these forward-looking statements as a
result of many factors, including those discussed under Part I, Item 1A. Risk
Factors in our Annual Report on Form 10-K filed with the SEC on March 1, 2022.

The following is a discussion of our consolidated results of operations for the three months ended March 31, 2022 and 2021.



                                                                       For the Three Months
                                                                          Ended March 31,
(in thousands)                                                                      2022               2021            Variance
Revenues:
Commissions and fees                                                       

$ 242,848 $ 152,828 $ 90,020



Operating expenses:
Commissions, employee compensation and benefits                                   153,750             89,375            64,375
Other operating expenses                                                           36,442             16,875            19,567
Amortization expense                                                               17,562             10,537             7,025
Change in fair value of contingent consideration                                   (5,632)            (1,503)           (4,129)
Depreciation expense                                                                  988                594               394
Total operating expenses                                                          203,110            115,878            87,232

Operating income                                                                   39,738             36,950             2,788

Other income (expense):
Interest expense, net                                                             (10,350)            (5,643)           (4,707)
Other income, net                                                                  15,451                  -            15,451
Total other income (expense)                                                        5,101             (5,643)           10,744

Net income                                                                         44,839             31,307            13,532
Less: net income attributable to noncontrolling interests                          21,970             16,001             5,969
Net income attributable to BRP Group, Inc.                                      $  22,869          $  15,306          $  7,563


                                                                              24

--------------------------------------------------------------------------------

Commissions and Fees



We earn commissions and fees by facilitating the arrangement between Insurance
Company Partners and individuals or businesses for the carrier to provide
insurance to the insured party. Our commissions and fees are usually a
percentage of the premium paid by the insured and generally depends on the type
of insurance, the particular Insurance Company Partner and the nature of the
services provided. Under certain arrangements with Clients, we earn
pre-negotiated service fees in lieu of commissions. Additionally, we may also
receive from Insurance Company Partners a profit-sharing commission, or straight
override, which represent forms of variable consideration associated with the
placement of coverage and are based primarily on underwriting results, but may
also contain considerations for volume, growth or retention.

Commissions and fees increased $90.0 million for the three months ended March
31, 2022 as compared to the same period of 2021. This increase was related to
amounts attributable to Partners acquired during 2021 and 2022 prior to their
having reached the twelve-month owned mark (such amounts, the "Partnership
Contribution") and organic growth. The Partnership Contribution accounted for
$64.8 million of the increase to commissions and fees for the quarter, and
organic growth accounted for $25.2 million of the increase for the quarter.

Major Sources of Commissions and Fees



The following table sets forth our commissions and fees by major source for the
periods indicated:

                                                           For the Three Months
                                                              Ended March 31,
  (in thousands)                                                           2022           2021         Variance
  Direct bill revenue                                                   $ 131,660      $  94,505      $ 37,155
  Agency bill revenue                                                      73,177         35,340        37,837
  Profit-sharing revenue                                                   15,012         10,292         4,720
  Consulting and service fee revenue                                       

14,337 7,007 7,330


  Policy fee and installment fee revenue                                    

5,708 4,476 1,232


  Other income                                                              

2,954 1,208 1,746


  Total commissions and fees                                            $ 

242,848 $ 152,828 $ 90,020




Direct bill revenue represents commission revenue earned by providing insurance
placement services to Clients, primarily for private risk management, commercial
risk management, employee benefits and Medicare insurance types. Direct bill
revenue increased by $37.2 million for the three months ended March 31, 2022 as
compared to the same period of 2021. The Partnership Contribution accounted for
$25.7 million of the increase to direct bill revenue for the quarter. Organic
growth for direct bill revenue was $11.5 million for the quarter.

Agency bill revenue primarily represents commission revenue earned by providing
insurance placement services to clients wherein we act as an agent on behalf of
the Client. Agency bill revenue increased $37.8 million for the three months
ended March 31, 2022 as compared to the same period of 2021. The Partnership
Contribution accounted for $27.7 million of the increase to agency bill revenue
for the quarter. Organic growth for agency bill revenue was $10.1 million for
the quarter.

Profit-sharing revenue represents bonus-type or contingent revenue that is
earned by us as a sales incentive provided by certain Insurance Company
Partners. Profit-sharing revenue increased $4.7 million for the three months
ended March 31, 2022 as compared to the same period of 2021 as a result of the
Partnership Contribution of $3.6 million and organic growth of $1.1 million.
Profit-sharing revenue was affected by higher loss ratios in our Middle Market
and MainStreet Operating Groups, which is particularly acute in the Florida
homeowners marketplace.

Consulting and service fee revenue represents fees received in lieu of a
commission and specialty insurance consulting revenue. Consulting and service
fee revenue increased $7.3 million for the three months ended March 31, 2022 as
compared to the same period of 2021 as a result of the Partnership Contribution
of $6.1 million and organic growth of $1.2 million.

Policy fee and installment fee revenue represents revenue earned for acting in
the capacity of an MGA and providing payment processing and services and other
administrative functions on behalf of Insurance Company Partners. Policy fee and
installment fee revenue increased $1.2 million during the three months ended
March 31, 2022 as compared to the same period of 2021 primarily due to organic
growth. These fees are generated by our Specialty Operating Group.

                                                                            

25

--------------------------------------------------------------------------------

Commissions, Employee Compensation and Benefits



Commissions, employee compensation and benefits is our largest expense. It
consists of (a) base compensation comprising salary, bonuses and benefits paid
and payable to Colleagues, commissions paid to Colleagues and outside
commissions paid to others; and (b) equity-based compensation associated with
the grants of restricted and unrestricted stock awards to senior management,
Colleagues, Risk Advisors and directors. We expect to continue to experience a
general rise in commissions, employee compensation and benefits expense
commensurate with expected growth in our revenue and headcount. We operate in
competitive markets for human capital and need to maintain competitive
compensation levels as we expand geographically and create new products and
services.

Our compensation arrangements with our employees contain significant bonus or
commission components driven by the results of our operations. Therefore, as we
grow commissions and fees, we expect compensation costs to rise.

Commissions, employee compensation and benefits expenses increased $64.4 million
for the three months ended March 31, 2022 as compared to the same period of
2021. The Partnership Contribution accounted for $36.9 million of the increase
to commissions, employee compensation and benefits for the quarter. Share-based
compensation expense increased $4.0 million, as a result of equity grants
awarded to all newly hired Colleagues, including those who joined us through
Partnerships, and grants to reward Colleagues, including members of senior
management. The remaining increase in commissions, employee compensation and
benefits expense can be attributed to higher commissions expense relating to our
organic growth and higher compensation and benefits relating to hiring to
support our growth.

Other Operating Expenses



Other operating expenses include travel, accounting, legal and other
professional fees, placement fees, rent, office expenses and other costs
associated with our operations. Our occupancy-related costs and professional
services expenses, in particular, generally increase or decrease in relative
proportion to the number of our employees and the overall size and scale of our
business operations.

Other operating expenses increased $19.6 million for the three months ended
March 31, 2022, which was primarily attributable to increases in professional
fees of $4.8 million relating to Partnership transactions, debt raises and
public filings, dues and subscriptions of $2.4 million from our investment in
technology to support our growth, rent expense of $2.2 million relating to
expansion of our operating locations, travel and entertainment of $2.0 million
relating to Partnership travel and lodging costs, licenses and taxes of $1.4
million relating to revenue growth, colleague education and welfare of $1.3
million relating to investments in our Colleagues, advertising and marketing of
$1.2 million and repairs and maintenance of $1.0 million.

Amortization Expense



Amortization expense increased $7.0 million for the three months ended March 31,
2022 as compared to the same period of 2021, which was driven by amortization
related to Partners acquired over the past twelve months.

Change in Fair Value of Contingent Consideration



Change in fair value of contingent consideration was favorable $4.1 million due
to $5.6 million gain for the three months ended March 31, 2022 as compared to a
$1.5 million gain for the same period of 2021. The change in fair value of
contingent consideration results from fluctuations in the value of the relevant
measurement basis, normally revenue or EBITDA, of our Partners.

Interest Expense, Net



Interest expense, net increased $4.7 million for the three months ended March
31, 2022 as compared to the same period of 2021 resulting from higher average
borrowings outstanding during the current year.

Other Income, Net



Other income, net was $15.5 million for the three months ended March 31, 2022,
primarily as a result of a fair value gain of $15.8 million recorded for our
interest rate caps during the period in connection with rising interest rates
and market estimates for future rate increases.

                                                                            

26

--------------------------------------------------------------------------------

NON-GAAP FINANCIAL MEASURES



Adjusted EBITDA, Adjusted EBITDA Margin, Organic Revenue, Organic Revenue
Growth, Adjusted Net Income and Adjusted Diluted Earnings Per Share ("EPS"), are
not measures of financial performance under GAAP and should not be considered
substitutes for GAAP measures, including commissions and fees (for Organic
Revenue and Organic Revenue Growth), net income (loss) (for Adjusted EBITDA and
Adjusted EBITDA Margin) net income (loss) attributable to BRP Group, Inc. (for
Adjusted Net Income) or diluted earnings (loss) per share (for Adjusted Diluted
EPS), which we consider to be the most directly comparable GAAP measures. These
non-GAAP financial measures have limitations as analytical tools, and when
assessing our operating performance, you should not consider these non-GAAP
financial measures in isolation or as substitutes for commissions and fees, net
income (loss), net income (loss) attributable to BRP Group, Inc. or other
consolidated income statement data prepared in accordance with GAAP. Other
companies in our industry may define or calculate these non-GAAP financial
measures differently than we do, and accordingly these measures may not be
comparable to similarly titled measures used by other companies.

We define Adjusted EBITDA as net income (loss) before interest, taxes,
depreciation, amortization, change in fair value of contingent consideration and
certain items of income and expense, including share-based compensation expense,
transaction-related expenses related to Partnerships, severance, and certain
non-recurring costs, including those related to raising capital. We believe that
Adjusted EBITDA is an appropriate measure of operating performance because it
eliminates the impact of expenses that do not relate to business performance,
and that the presentation of this measure enhances an investor's understanding
of our financial performance.

Adjusted EBITDA Margin is Adjusted EBITDA divided by commissions and fees.
Adjusted EBITDA Margin is a key metric used by management and our board of
directors to assess our financial performance. We believe that Adjusted EBITDA
Margin is an appropriate measure of operating performance because it eliminates
the impact of expenses that do not relate to business performance, and that the
presentation of this measure enhances an investor's understanding of our
financial performance. We believe that Adjusted EBITDA Margin is helpful in
measuring profitability of operations on a consolidated level.

Adjusted EBITDA and Adjusted EBITDA Margin have important limitations as analytical tools. For example, Adjusted EBITDA and Adjusted EBITDA Margin:

•do not reflect any cash capital expenditure requirements for the assets being depreciated and amortized that may have to be replaced in the future;

•do not reflect changes in, or cash requirements for, our working capital needs;

•do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations;

•do not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our debt;

•do not reflect share-based compensation expense and other non-cash charges; and

•exclude certain tax payments that may represent a reduction in cash available to us.



We calculate Organic Revenue Growth based on commissions and fees for the
relevant period by excluding the first twelve months of commissions and fees
generated from new Partners. Organic Revenue Growth is the change in Organic
Revenue period-to-period, with prior period results adjusted for Organic
Revenues that were excluded in the prior period because the relevant Partners
had not yet reached the twelve-month owned mark, but which have reached the
twelve-month owned mark in the current period. For example, revenues from a
Partner acquired on June 1, 2021 are excluded from Organic Revenue for 2021.
However, after June 1, 2022, results from June 1, 2021 to December 31, 2021 for
such Partners are compared to results from June 1, 2022 to December 31, 2022 for
purposes of calculating Organic Revenue Growth in 2022. Organic Revenue Growth
is a key metric used by management and our board of directors to assess our
financial performance. We believe that Organic Revenue and Organic Revenue
Growth are appropriate measures of operating performance as they allow investors
to measure, analyze and compare growth in a meaningful and consistent manner.

Adjusted Net Income is presented for the purpose of calculating Adjusted Diluted
EPS. We define Adjusted Net Income as net income (loss) attributable to BRP
Group, Inc. adjusted for depreciation, amortization, change in fair value of
contingent consideration and certain items of income and expense, including
share-based compensation expense, transaction-related expenses related to
Partnerships, severance, and certain non-recurring costs that, in the opinion of
management, significantly affect the period-over-period assessment of operating
results, and the related tax effect of those adjustments.

                                                                            

27

--------------------------------------------------------------------------------



Adjusted Diluted EPS measures our per share earnings excluding certain expenses
as discussed above and assuming all shares of Class B common stock were
exchanged for Class A common stock. Adjusted Diluted EPS is calculated as
Adjusted Net Income divided by adjusted dilutive weighted-average shares
outstanding. We believe Adjusted Diluted EPS is useful to investors because it
enables them to better evaluate per share operating performance across reporting
periods.

Adjusted EBITDA and Adjusted EBITDA Margin



The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to net
income, which we consider to be the most directly comparable GAAP financial
measure:

                                                                For the Three Months
                                                                   Ended March 31,
(in thousands, except percentages)                                              2022          2021(1)
Commissions and fees                                                        $ 242,848       $ 152,828

Net income                                                                  $  44,839       $  31,307
Adjustments to net income:
Amortization expense                                                           17,562          10,537
Change in fair value of interest rate caps                                    (15,810)              -
Interest expense, net                                                          10,350           5,643
Transaction-related Partnership expenses                                        8,216           2,445
Share-based compensation                                                        7,564           3,542
Change in fair value of contingent consideration                               (5,632)         (1,503)
Depreciation expense                                                              988             594
Severance                                                                         222               -
Other(2)                                                                        4,633             859
Adjusted EBITDA                                                             $  72,932       $  53,424
Adjusted EBITDA Margin                                                             30  %           35  %


__________
(1)  We revised operating expenses for the three months ended March 31, 2021 to
reflect the adoption of Topic 842 as described further in Note 1 to the
condensed consolidated financial statements included in Item 1. Financial
Statements. This adjustment affected net income and Adjusted EBITDA values.
(2)  Other addbacks to Adjusted EBITDA include non-recurring recruiting costs,
non-recurring remediation efforts, non-recurring professional fees and
litigation costs, and non-recurring bonuses.

Organic Revenue and Organic Revenue Growth



The following table reconciles Organic Revenue and Organic Revenue Growth to
commissions and fees, which we consider to be the most directly comparable GAAP
financial measure:

                                                           For the Three Months
                                                              Ended March 31,
       (in thousands, except percentages)                                  2022            2021
       Commissions and fees                                            $

242,848 $ 152,828


       Partnership commissions and fees(1)                              

(64,777) (91,215)


       Organic Revenue                                                 $

178,071 $ 61,613


       Organic Revenue Growth(2)                                       $ 

25,181 $ 7,447


       Organic Revenue Growth %(2)                                            16  %           14  %


__________


(1)  Includes the first twelve months of such commissions and fees generated
from newly acquired Partners.
(2)  Organic Revenue Growth for the three months ended March 31, 2021 used to
calculate Organic Revenue for the three months ended March 31, 2022 was $152.9
million, which is adjusted to reflect revenues from Partnerships that reached
the twelve-month owned mark during the three months ended March 31, 2022.

                                                                            

28

--------------------------------------------------------------------------------

Adjusted Net Income and Adjusted Diluted EPS

The following table reconciles Adjusted Net Income to net income attributable to BRP Group, Inc. and reconciles Adjusted Diluted EPS to diluted earnings per share, which we consider to be the most directly comparable GAAP financial measures:



                                                                             For the Three Months
                                                                                Ended March 31,
(in thousands, except per share data)                                                     2022             2021(1)(2)
Net income attributable to BRP Group, Inc.                                            $  22,869          $    15,306
Net income attributable to noncontrolling interests                                      21,970               16,001
Amortization expense                                                                     17,562               10,537
Change in fair value of interest rate caps                                              (15,810)                   -
Transaction-related Partnership expenses                                                  8,216                2,445
Share-based compensation                                                                  7,564                3,542
Change in fair value of contingent consideration                                         (5,632)              (1,503)
Amortization of deferred financing costs                                                  1,286                  693
Depreciation                                                                                988                  594
Severance                                                                                   222                    -
Other(3)                                                                                  4,633                  859
Adjusted pre-tax income                                                                  63,868               48,474
Adjusted income taxes(4)                                                                  6,323                4,799
Adjusted Net Income                                                                   $  57,545          $    43,675

Weighted-average shares of Class A common stock outstanding - diluted

                                                                                  58,716               45,783
Exchange of Class B shares(5)                                                            56,269               49,789
Adjusted dilutive weighted-average shares outstanding                                   114,985               95,572

Adjusted Diluted EPS                                                                  $    0.50          $      0.46

Diluted earnings per share                                                            $    0.39          $      0.33
Other adjustments to earnings per share                                                    0.16                 0.18
Adjusted income taxes per share                                                           (0.05)               (0.05)
Adjusted Diluted EPS                                                                  $    0.50          $      0.46


___________
(1)  We revised operating expenses for the three months ended March 31, 2021 to
reflect the adoption of Topic 842 as described further in Note 1 to the
condensed consolidated financial statements included in Item 1. Financial
Statements This adjustment affected net income attributable to BRP Group, Inc.
and Adjusted Net Income values as well as diluted earnings per share and
Adjusted Diluted EPS.
(2)  Calculation was adjusted in the fourth quarter of 2021 to include
depreciation. Prior year amounts have been conformed to current year
presentation.
(3)  Other addbacks to Adjusted EBITDA include non-recurring recruiting costs,
non-recurring remediation efforts, non-recurring professional fees and
litigation costs, and non-recurring bonuses.
(4)  Represents corporate income taxes at assumed effective tax rate of 9.9%
applied to adjusted pre-tax income.
(5)  Assumes the full exchange of Class B shares for Class A common stock
pursuant to the Amended LLC Agreement.

                                                                            

29

--------------------------------------------------------------------------------

OPERATING GROUP RESULTS

Commissions and Fees



In the Middle Market, MainStreet and Specialty Operating Groups, we generate
commissions and fees from insurance placement under both agency bill and direct
bill arrangements. In addition, we generate profit-sharing income in each of
those segments based on either the underlying Book of Business or performance,
such as loss ratios. In the Middle Market and Specialty Operating Groups, we
generate fees from service fee and consulting arrangements. Service fee
arrangements are in place with certain customers in lieu of commission
arrangements.

In the Specialty Operating Group, we generate policy fee and installment fee
revenue for acting in the capacity of an MGA and fulfilling certain services on
behalf of Insurance Company Partners.

In the Medicare Operating Group, we generate commissions and fees in the form of
direct bill insurance placement and marketing income. Marketing income is earned
through co-branded marketing campaigns with our Insurance Company Partners.

The following table sets forth our commissions and fees by Operating Group and
for Corporate and Other by amount and as a percentage of our commissions and
fees:

                       Commissions and Fees by Operating Group (in 

thousands, except percentages)


                                                                                                            For the Three Months
                                                                                                               Ended March 31,
                                                                                                            2022               2021                Variance
                                                                                                                                            Percent of                  Percent of
Operating Group                                                                                                                 Amount       Business       Amount       Business      Amount        %
Middle Market                                                                                                                $ 171,403             70  % $ 110,555             72  % $ 60,848        55  %
Specialty                                                                                                                       49,523             20  %    25,082             17  %   24,441        97  %
MainStreet                                                                                                                       9,277              4  %     8,222              5  %    1,055        13  %
Medicare                                                                                                                        13,681              6  %     9,452              6  %    4,229        45  %
Corporate and Other                                                                                                             (1,036)             -  %      (483)             -  %     (553)      114  %
                                                                                                                             $ 242,848                   $ 152,828                   $ 90,020


Commissions and fees for our Middle Market Operating Group increased $60.8
million for the three months ended March 31, 2022 as compared to the same period
of 2021 as a result of the Partnership Contribution of $46.9 million and organic
growth of $13.9 million concentrated in base commissions and fees.

Commissions and fees for our Specialty Operating Group increased $24.4 million
for the three months ended March 31, 2022 as compared to the same period of 2021
as a result of the Partnership Contribution of $16.7 million and organic growth
of $7.7 million, which is attributable to growth in our renter's insurance
product.

Commissions and fees for our MainStreet Operating Group increased $1.1 million
for the three months ended March 31, 2022 as compared to the same period of 2021
as a result of organic growth, primarily related to base commissions and fees.

Commissions and fees for our Medicare Operating Group increased $4.2 million for
the three months ended March 31, 2022 as compared to the same period of 2021 as
a result of organic growth of $2.5 million and the Partnership Contribution of
$1.7 million.

Revenue reported for Corporate and Other relates to the elimination of
intercompany revenue. During the three months ended March 31, 2022, the Middle
Market Operating Group recorded intercompany commissions and fees from activity
with the Specialty Operating Group of $0.3 million; the Specialty Operating
Group recorded intercompany commissions and fees revenue from activity with
itself of $0.1 million; the MainStreet Operating Group recorded intercompany
commissions and fees from activity with the Middle Market Operating Group of
less than $0.1 million; and the Medicare Operating Group recorded intercompany
commissions and fees from activity with itself of $0.6 million. These amounts
were eliminated through Corporate and Other.

                                                                            

30

--------------------------------------------------------------------------------

Commissions, Employee Compensation and Benefits

The following table sets forth our commissions, employee compensation and benefits by Operating Group and for Corporate and Other by amount and as a percentage of our commissions, employee compensation and benefits:



                       Commissions, Employee Compensation and Benefits by 

Operating Group (in thousands, except percentages)


                                                                                                                               For the Three Months
                                                                                                                                  Ended March 31,
                                                                                                                               2022                      2021                Variance
                                                                                                                                                                      Percent of                 Percent of
Operating Group                                                                                                                                           Amount       Business      Amount       Business      Amount        %
Middle Market                                                                                                                                          $  94,790             62  % $ 56,742             63  % $ 38,048        67  %
Specialty                                                                                                                                                 34,676             22  %   17,952             20  %   16,724        93  %
MainStreet                                                                                                                                                 7,504              5  %    5,146              6  %    2,358        46  %
Medicare                                                                                                                                                   7,369              5  %    4,578              5  %    2,791        61  %
Corporate and Other                                                                                                                                        9,411              6  %    4,957              6  %    4,454        90  %
                                                                                                                                                       $ 153,750                   $ 89,375                   $ 64,375


Commissions, employee compensation and benefits expenses increased across all
Operating Groups for the three months ended March 31, 2022 as compared to the
same period of 2021. The Partnership Contribution accounted for $26.5 million,
$9.9 million and $0.5 million of the increase to commissions, employee
compensation and benefits expenses in the Middle Market, Specialty and Medicare
Operating Groups, respectively. Commissions, employee compensation and benefits
expenses also increased across all Operating Groups as a result of continued
investments in hiring for our Growth Services team to support our growth, which
costs are primarily allocated among the Operating Groups, and continued
investment in sales and service talent.

Commissions, employee compensation and benefits expenses for Corporate and Other
increased $4.5 million for the three months ended March 31, 2022 as compared to
the same period of 2021 as a result of continued investments in hiring to
support our growth and additional share-based compensation expense.

Other Operating Expenses



The following table sets forth our other operating expenses by Operating Group
and for Corporate and Other by amount and as a percentage of our other operating
expenses:

                       Other Operating Expenses by Operating Group (in 

thousands, except percentages)


                                                                                                              For the Three Months
                                                                                                                 Ended March 31,
                                                                                                              2022                 2021               Variance
                                                                                                                                               Percent of                 Percent of
Operating Group                                                                                                                    Amount       Business      Amount       Business      Amount        %
Middle Market                                                                                                                    $ 14,509             40  % $  7,600             45  % $  6,909        91  %
Specialty                                                                                                                           5,380             15  %    1,867             11  %    3,513       188  %
MainStreet                                                                                                                          3,006              8  %    1,035              6  %    1,971       190  %
Medicare                                                                                                                            1,142              3  %    1,372              8  %     (230)      (17) %
Corporate and Other                                                                                                                12,405             34  %    5,001             30  %    7,404       148  %
                                                                                                                                 $ 36,442                   $ 16,875                   $ 19,567


                                                                              31

--------------------------------------------------------------------------------



Other operating expenses for our Middle Market Operating Group increased $6.9
million for the three months ended March 31, 2022 as compared to the same period
of 2021 driven by higher costs for travel and entertainment of $1.3 million,
rent expense of $1.3 million, professional fees of $1.1 million, dues and
subscriptions of $0.7 million, advertising and marketing of $0.6 million and
colleague education and welfare of $0.5 million. Other operating expenses for
our Specialty Operating Group increased $3.5 million for the three months ended
March 31, 2022 as compared to the same period of 2021 driven by higher costs for
professional fees of $0.8 million, advertising and marketing of $0.4 million,
travel and entertainment, dues and subscriptions and rent expense of $0.3
million each, and colleague education and welfare, consulting fees, and licenses
and taxes of $0.2 million each. Other operating expenses for our MainStreet
Operating Group increased $2.0 million for the three months ended March 31, 2022
as compared to the same period of 2021 driven by higher professional fees. Other
operating expenses for our Medicare Operating Group decreased $0.2 million for
the three months ended March 31, 2022 as compared to the same period of 2021
driven by lower professional fees. The increases in our operating costs are
related to our growth, both organically and through Partnerships, during the
previous twelve months.

Other operating expenses in Corporate and Other increased $7.4 million for the
three months ended March 31, 2022 as compared to the same period of 2021 due to
higher costs for professional fees of $1.9 million, dues and subscriptions of
$1.3 million, licenses and taxes of $1.0 million, consulting fees of $0.7
million, recruiting expense of $0.7 million and colleague education and welfare
of $0.5 million.

Amortization Expense

The following table sets forth our amortization by Operating Group and for Corporate and Other by amount and as a percentage of our amortization:



                       Amortization Expense by Operating Group (in 

thousands, except percentages)


                                                                                                            For the Three Months
                                                                                                               Ended March 31,
                                                                                                            2022               2021               Variance
                                                                                                                                           Percent of                 Percent of
Operating Group                                                                                                                Amount       Business      Amount       Business      Amount        %
Middle Market                                                                                                                $ 12,548             72  % $  7,449             71  % $  5,099        68  %
Specialty                                                                                                                       4,193             24  %    2,309             22  %    1,884        82  %
MainStreet                                                                                                                        393              2  %      416              4  %      (23)       (6) %
Medicare                                                                                                                          427              2  %      363              3  %       64        18  %
Corporate and Other                                                                                                                 1              -  %        -              -  %        1         -  %
                                                                                                                             $ 17,562                   $ 10,537                   $  7,025


Amortization expense increased for our Middle Market and Specialty Operating
Groups for the three months ended March 31, 2022 as compared to the same period
of 2021 driven by amortization related to Partners acquired over the past twelve
months. Amortization expense for the MainStreet and Medicare Operating Groups
was relatively flat.

Change in Fair Value of Contingent Consideration

The following table sets forth our change in fair value of contingent consideration by Operating Group by amount and as a percentage of our change in fair value of contingent consideration:



                     Change in Fair Value of Contingent Consideration by 

Operating Group (in thousands, except percentages)


                                                                                                                             For the Three Months
                                                                                                                                Ended March 31,
                                                                                                                             2022                      2021               Variance
                                                                                                                                                                   Percent of                 Percent of
Operating Group                                                                                                                                        Amount       Business      Amount       Business      Amount        %
Middle Market                                                                                                                                        $ (6,055)           108  % $ (3,523)           234  % $ (2,532)        72  %
Specialty                                                                                                                                                (183)             3  %    1,035            (69) %   (1,218)      (118) %
MainStreet                                                                                                                                                180             (3) %      193            (13) %      (13)        (7) %
Medicare                                                                                                                                                  426             (8) %      792            (53) %     (366)       (46) %
                                                                                                                                                     $ (5,632)                  $ (1,503)                  $ (4,129)


                                                                              32

--------------------------------------------------------------------------------



The change in fair value of contingent consideration results from fluctuations
in the value of the relevant measurement basis, normally revenue or EBITDA of
our Partners.

LIQUIDITY AND CAPITAL RESOURCES



Our primary liquidity needs for the foreseeable future will include cash to
(i) provide capital to facilitate the organic growth of our business and to fund
future Partnerships, (ii) pay operating expenses, including cash compensation to
our employees and expenses related to being a public company, (iii) make
payments under the Tax Receivable Agreement, (iv) pay interest and principal due
on borrowings under the JPM Credit Agreement, (v) pay contingent earnout
liabilities and related short-term notes payable due April 2022, and (vi) pay
income taxes. We have historically financed our operations and funded our debt
service through the sale of our insurance products and services. In addition, we
have financed significant cash needs to fund growth through the acquisition of
Partners through debt and equity financing.

At March 31, 2022, our cash and cash equivalents were $156.8 million. We believe
that our cash and cash equivalents, cash flow from operations and available
borrowings under the JPM Credit Agreement will be sufficient to fund our working
capital and meet our commitments for the foreseeable future. However, we expect
that we will require additional funding to continue to execute on our
Partnership strategy. Such funding could include the incurrence of additional
debt and the issuance of equity. Additional funds may not be available on a
timely basis, on favorable terms, or at all, and such funds, if raised, may not
be sufficient to enable us to continue to implement our long-term Partnership
strategy. If we are not able to raise funds when needed, we could be forced to
delay or reduce the number of Partnerships that we complete.

JPM Credit Agreement



As of December 31, 2021, our credit agreement with JPMorgan Chase Bank, N.A.,
provided for senior secured credit facilities in an aggregate principal amount
of $1.325 billion (the "JPM Credit Agreement"), which consisted of (i) a term
loan facility in the principal amount of $850.0 million maturing in 2027 (the
"Term Loan B") and (ii) a revolving credit facility with commitments in an
aggregate principal amount of $475.0 million maturing in 2025 (the "Revolving
Facility").

On March 28, 2022, the Company entered into Amendment No. 5 to the JPM Credit
Agreement, under which (i) the aggregate principal amount of the Revolving
Facility was increased from $475.0 million to $600.0 million and (ii) the
interest rate on the Revolving Facility changed to the Secured Overnight
Financing Rate ("SOFR"), plus a credit spread adjustment of 10 basis points
("bps"), plus an amount between 200 bps and 300 bps based on the total net
leverage ratio, (iii) the total net leverage ratio covenant increased to 7.0x
consolidated EBITDA and (iv) the maturity of the Revolving Facility was extended
to April 1, 2027. The other terms of the Revolving Facility and the terms of the
Term Loan B remained unchanged.

The Term Loan B bears interest at LIBOR plus 350 bps, subject to a LIBOR floor
of 50 bps. The applicable interest rate on the Term Loan B at March 31, 2022 was
4.00%. Borrowings under the Revolving Facility accrue interest at SOFR plus 210
bps to SOFR plus 310 bps based on total net leverage ratio. BRP will pay a
letter of credit fee equal to the margin then in effect with respect to SOFR
loans under the Revolving Facility multiplied by the daily amount available to
be drawn under any letter of credit, a fronting fee and any customary
documentary and processing charges for any letter of credit issued under the JPM
Credit Agreement. The outstanding borrowings on the Revolving Facility of $75.0
million had an applicable interest rate of 3.35% at March 31, 2022. The
Revolving Facility is also subject to a commitment fee of 0.40% on the unused
capacity at March 31, 2022. We subsequently increased our borrowings under the
Revolving Facility to $530.0 million.

The Revolving Facility and the Term Loan B are collateralized by a first
priority lien on substantially all the assets of BRP, including a pledge of all
equity securities of certain of its subsidiaries. The JPM Credit Agreement
contains covenants that, among other things, restrict our ability to make
certain restricted payments, incur additional debt, engage in certain asset
sales, mergers, acquisitions or similar transactions, create liens on assets,
engage in certain transactions with affiliates, change our business, make
certain investments or restrict BRP's ability to make dividends or other
distributions to BRP Group. In addition, the JPM Credit Agreement contains
financial covenants requiring us to maintain our Total First Lien Net Leverage
Ratio (as defined in the JPM Credit Agreement) at or below 7.00 to 1.00.

                                                                            

33

--------------------------------------------------------------------------------

Contractual Obligations and Commitments



The following table represents our contractual obligations, aggregated by type,
at March 31, 2022:

                                                                           Payments Due by Period
                                                              Less than                                                  More than
(in thousands)                              Total               1 year            1-3 years           3-5 years           5 years
Operating leases (1)                    $    97,189          $  16,064

$ 30,191 $ 24,706 $ 26,228 Debt obligations payable (2)

              1,175,516            106,143               88,263             86,900            894,210
Maximum future acquisition contingency
payments (3)                                968,996             66,075              892,921             10,000                  -
Total                                   $ 2,241,701          $ 188,282          $ 1,011,375          $ 121,606          $ 920,438


__________
(1)  The Company leases facilities and equipment under noncancelable operating
leases. Rent expense was $6.1 million and $4.0 million for the three months
ended March 31, 2022 and 2021, respectively.
(2)  Represents scheduled debt obligations and estimated interest payments under
the JPM Credit Agreement and obligations under our related party notes payable.
(3)  Includes $227.8 million of current and non-current estimated contingent
earnout liabilities at March 31, 2022.

Tax Receivable Agreement



We expect to obtain an increase in our share of our tax basis of the assets when
BRP's LLC Units are redeemed or exchanged for shares of BRP Group's Class A
common stock. This increase in tax basis may have the effect of reducing the
future amounts paid to various tax authorities. The increase in tax basis may
also decrease gains (or increase losses) on future dispositions of certain
capital assets to the extent tax basis is allocated to those capital assets.

We have a Tax Receivable Agreement that provides for the payment by us to the
parties to the Tax Receivable Agreement of 85% of the amount of cash savings, if
any, in U.S. federal, state and local income tax or franchise tax that we
actually realize as a result of (i) any increase in tax basis in BRP Group's
assets and (ii) tax benefits related to imputed interest deemed arising as a
result of payments made under the tax receivable agreement.

During the three months ended March 31, 2022, we redeemed 70,000 LLC Units of
BRP on a one-for-one basis for shares of Class A common stock and cancelled the
corresponding shares of Class B common stock, which triggered an increase in BRP
Group's tax basis but did not result in a tax benefit to the LLC Unit holders.

SOURCES AND USES OF CASH

The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated:



                                                            For the Three Months
                                                               Ended March 31,
(in thousands)                                             2022                2021             Variance

Net cash provided by (used in) operating activities $ (3,433) $ 3,287 $ (6,720) Net cash used in investing activities

                      (3,132)           (18,358)            15,226

Net cash provided by (used in) financing activities 22,736

   (4,404)            27,140

Net increase (decrease) in cash and cash equivalents and restricted cash

                                        16,171            (19,475)            35,646
Cash and cash equivalents and restricted cash at
beginning of period                                       227,737            142,022             85,715

Cash and cash equivalents and restricted cash at end of period

$   243,908

$ 122,547 $ 121,361

Operating Activities



The primary sources and uses of cash for operating activities are net income
adjusted for non-cash items and changes in assets and liabilities, or operating
working capital. Net cash provided by operating activities decreased $6.7
million for the first quarter of 2022 as compared to the same period of 2021
primarily as a result of payments of contingent earnout consideration in excess
of purchase price accrual.

                                                                              34

--------------------------------------------------------------------------------

Investing Activities



The primary sources and uses of cash for investing activities relate to cash
consideration paid to fund Partnerships and other investments, as well as
capital expenditures. Net cash used in investing activities decreased $15.2
million for the first quarter of 2022 as compared to the same period of 2021
driven by a decrease in cash consideration paid for business combinations and
assets acquisitions of $16.7 million.

Financing Activities



The primary sources and uses of cash for financing activities relate to the
issuance of our Class A common stock, borrowings from and repayment to our
credit agreements, payment of debt issuance costs, payment of contingent earnout
consideration, and other equity transactions. Net cash provided by financing
activities increased $27.1 million for the first quarter of 2022 as compared to
the same period of 2021 primarily as a result of borrowings on our revolving
line of credit of $40.0 million during the first quarter of 2022, offset in part
by payments of contingent earnout consideration up to amount of purchase price
accrual of $14.0 million.

CRITICAL ACCOUNTING ESTIMATES

In preparing our financial statements in accordance with GAAP, we are required
to make estimates and assumptions that affect the amounts of assets,
liabilities, revenue, expenses, disclosure of contingent assets and liabilities
and accompanying disclosures. We evaluate our estimates and assumptions on an
ongoing basis. These estimates are based on historical experience and various
other assumptions that we believe to be reasonable under the circumstances;
although, actual results may differ from these estimates and assumptions. To the
extent that there are differences between our estimates and actual results, our
financial condition, results of operations and cash flows will be affected.

There have been no material changes in our critical accounting policies during
the three months ended March 31, 2022 as compared to those disclosed in the
Critical Accounting Estimates section under Management's Discussion and Analysis
of Financial Condition and Results of Operations of our Annual Report on Form
10-K filed with the SEC on March 1, 2022.

RECENT ACCOUNTING PRONOUNCEMENTS

Please refer to Note 1 to our condensed consolidated financial statements included in Item 1. Financial Statements of this report for a discussion of recent accounting pronouncements that may impact us.

© Edgar Online, source Glimpses